Mandate

Vinge advises Fidelio Capital in connection with acquisition of BioMedtrix

March 18, 2020 M&A

Vinge has advised Fidelio Capital on the acquisition of BioMedtrix, LLC. BioMedtrix is a leading company within the market for veterinary orthopedic implants and instruments.

The company is based in New Jersey, USA, and sells its products to over 35 markets world-wide.

Vinge’s team consisted of, among others, Jonas Bergström and Manne Bergström.

Related

Vinge advises Isofol Medical AB (publ) in connection with its rights issue of units

Through the rights issue of units, consisting of shares and warrants, and the exercised over-allotment issue, Isofol will receive approximately SEK 84 million and may receive an additional maximum of approximately SEK 110 million upon exercise of all warrants at the highest subscription price.
August 01, 2025

Vinge advises Oncorena in connection with share issue

Vinge advises Oncorena Holding AB in connection with a share issue of approximately SEK 133 million.
July 30, 2025

Vinge advises Karl Hedin and minority owners on the sale of AB Karl Hedin Sågverk to Vida

Vinge has advised Karl Hedin and minority shareholders in connection with the sale of AB Karl Hedin Sågverk to Vida Aktiebolag (“Vida”).
July 24, 2025